These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 1358381)

  • 1. The effects of beta 2-adrenoceptor agonists and a corticosteroid, budesonide, on the secretion of inflammatory mediators from monocytes.
    Linden M
    Br J Pharmacol; 1992 Sep; 107(1):156-60. PubMed ID: 1358381
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of beta2-agonists and budesonide on interleukin-1beta and leukotriene B4 secretion: studies of human monocytes and alveolar macrophages.
    Zetterlund A; Linden M; Larsson K
    J Asthma; 1998; 35(7):565-73. PubMed ID: 9777883
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Budesonide prevents cytokine-induced decrease of the relaxant responses to formoterol and terbutaline, but not to salmeterol, in mouse trachea.
    Adner M; Larsson B; Säfholm J; Naya I; Miller-Larsson A
    J Pharmacol Exp Ther; 2010 Apr; 333(1):273-80. PubMed ID: 20061444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of formoterol and salmeterol on cytokine release from monocyte-derived macrophages.
    Donnelly LE; Tudhope SJ; Fenwick PS; Barnes PJ
    Eur Respir J; 2010 Jul; 36(1):178-86. PubMed ID: 19926732
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Formoterol and salmeterol induce a similar degree of β2-adrenoceptor tolerance in human small airways but via different mechanisms.
    Cooper PR; Kurten RC; Zhang J; Nicholls DJ; Dainty IA; Panettieri RA
    Br J Pharmacol; 2011 Jun; 163(3):521-32. PubMed ID: 21306583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancement of inflammatory mediator release by beta(2)-adrenoceptor agonists in airway epithelial cells is reversed by glucocorticoid action.
    Holden NS; Rider CF; Bell MJ; Velayudhan J; King EM; Kaur M; Salmon M; Giembycz MA; Newton R
    Br J Pharmacol; 2010 May; 160(2):410-20. PubMed ID: 20423350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the anti-inflammatory properties of formoterol, salbutamol and salmeterol in guinea-pig skin and lung.
    Whelan CJ; Johnson M; Vardey CJ
    Br J Pharmacol; 1993 Oct; 110(2):613-8. PubMed ID: 7902175
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Salmeterol, formoterol, and salbutamol in the isolated guinea pig trachea: differences in maximum relaxant effect and potency but not in functional antagonism.
    Lindén A; Bergendal A; Ullman A; Skoogh BE; Löfdahl CG
    Thorax; 1993 May; 48(5):547-53. PubMed ID: 8100652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological similarities and differences between beta2-agonists.
    Lötvall J
    Respir Med; 2001 Aug; 95 Suppl B():S7-11. PubMed ID: 11534896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppressive effects of formoterol and salmeterol on eotaxin-1 in bronchial epithelial cells.
    Chu YT; Chang TT; Jong YJ; Kuo PL; Lee HM; Lee MS; Chang HW; Hung CH
    Pediatr Allergy Immunol; 2010 Mar; 21(2 Pt 1):345-52. PubMed ID: 20003162
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhaled corticosteroids or long-acting beta-agonists alone or in fixed-dose combinations in asthma treatment: a systematic review of fluticasone/budesonide and formoterol/salmeterol.
    Frois C; Wu EQ; Ray S; Colice GL
    Clin Ther; 2009 Dec; 31(12):2779-803. PubMed ID: 20110019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Salmeterol is a competitive antagonist at beta-adrenoceptors mediating inhibition of respiratory burst in guinea-pig eosinophils.
    Rabe KF; Giembycz MA; Dent G; Perkins RS; Evans P; Barnes PJ
    Eur J Pharmacol; 1993 Feb; 231(2):305-8. PubMed ID: 8095902
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long acting inhaled beta-adrenoceptor agonists the comparative pharmacology of formoterol and salmeterol.
    Anderson GP
    Agents Actions Suppl; 1993; 43():253-69. PubMed ID: 8103622
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Different effects of salmeterol, formoterol and salbutamol on cholinergic responses in the ferret trachea.
    Bergendal A; Lindén A; Lötvall J; Skoogh BE; Löfdahl CG
    Br J Pharmacol; 1995 Apr; 114(7):1478-82. PubMed ID: 7606351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies on the interaction between formoterol and salmeterol in guinea-pig trachea in vitro.
    Jeppsson AB; Källström BL; Waldeck B
    Pharmacol Toxicol; 1992 Oct; 71(4):272-7. PubMed ID: 1360657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beta2-agonists potentiate corticosteroid-induced neutrophil survival.
    Perttunen H; Moilanen E; Zhang X; Barnes PJ; Kankaanranta H
    COPD; 2008 Jun; 5(3):163-9. PubMed ID: 18568840
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Desensitisation of mast cell beta2-adrenoceptor-mediated responses by salmeterol and formoterol.
    Scola AM; Chong LK; Suvarna SK; Chess-Williams R; Peachell PT
    Br J Pharmacol; 2004 Jan; 141(1):163-71. PubMed ID: 14662724
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of salmeterol on human eosinophils is both stimulus- and response-dependent.
    Ezeamuzie CI; al-Hage M; Nwankwoala RN
    Int J Immunopharmacol; 1997 Aug; 19(8):421-30. PubMed ID: 9568547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relaxation kinetics of formoterol and salmeterol in the guinea pig trachea in vitro.
    Anderson P; Lötvall J; Lindén A
    Lung; 1996; 174(3):159-70. PubMed ID: 8830192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of beta2 adrenoceptor agonists on T-cell subpopulations.
    Holen E; Elsayed S
    APMIS; 1998 Sep; 106(9):849-57. PubMed ID: 9808411
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.